InSnip Pure Signal, No Noise

A friend shared this story with you

Mayne Pharma pivots to branded drugs, leaving generics behind
✓ Source-backedMoney & Work

Mayne Pharma pivots to branded drugs, leaving generics behind

Mayne Pharma's sales are now 83% branded drugs, up from 32% two years ago, focusing on dermatology and women's health.

Why it mattersBranded drugs command higher prices and better margins than generics. This shift strengthens Mayne's profitability and competitive position.

Know someone who should read this?

Read the full story on InSnip →

Free. Be genuinely informed in 5 minutes a day. No signup, no noise.

Get the free app, read the whole feed

Download on the App StoreGet it on Google Play

InSnip turns the day's news into short, source-backed snippets with a plain why it matters line. The signal, not the scroll.

More Money & Work on InSnip →